Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Prostatic Neoplasms
Clinical trial register · United States · industry-sponsored

Prostatic Neoplasms Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9164 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 27 Oct 2026, 03:16 UTC
9164
Studies in scope
industry-sponsored, all four open statuses
4968
Recruiting now
open to new participants
2200
Lead sponsors
across recruiting studies
Top states
Florida 16 California 14 Colorado 12 Arizona 11 New York 8
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Prostatic Neoplasms trials in the USA

24 of 9164 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Janssen Research & Development, LLC
Phase 2
100
Louisiana, Massachusetts, New York, Tennessee
2026-09-16
Recruiting
Janssen Research & Development, LLC
Phase 1
100
Florida, Michigan, Utah
2026-08-05
Recruiting
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07719361Metastatic Castration Resistant Prostate Cancer, mCRPC, mCRPC (Metastatic Castration-resistant Prostate Cancer), Prostatic Neoplasms
Flare Therapeutics Inc.
Phase 1
60
California, Massachusetts, Michigan, New Jersey, South Carolina, Tennessee, Texas
2026-07-01
Recruiting
Janssen Research & Development, LLC
Phase 1
40
Florida, New York, Ohio
2026-01-14
Recruiting
Janssen Research & Development, LLC
Phase 1
140
Florida, New York, Ohio, Washington
2025-07-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2025-05-13
Recruiting
A Study of DM002 in Patients With Advanced Solid Tumors
NCT06751329Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Colorectal Neoplasms
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Phase 1/2
280
California, North Carolina, Oklahoma, Texas
2025-02-17
Recruiting
Clarity Pharmaceuticals Ltd
Phase 3
383
Alabama, Arizona, Arkansas, California, Florida, Illinois, Indiana, Kansas
2023-12-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2023-12-18
Recruiting
Janssen Research & Development, LLC
Phase 1
355
Colorado, Georgia, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania
2023-11-01
Active, closed
Eli Lilly and Company
Phase 3
925
Arizona, Arkansas, California, Colorado, Florida, Georgia, Indiana, Kentucky
2022-04-14
Active, closed
Janssen Research & Development, LLC
Phase 1
216
New York, Washington
2021-07-13
Active, closed
Novartis Pharmaceuticals
Phase 3
469
Colorado, Florida, Louisiana, Massachusetts, Missouri, Nebraska, New York, North Carolina
2021-06-15
Active, closed
Novartis Pharmaceuticals
Phase 3
1,140
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Hawaii
2021-06-09
Active, closed
Janssen Research & Development, LLC
Phase 1
136
Utah
2020-11-13
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Arizona, Arkansas, Colorado, Florida, Indiana, Michigan, New York, Ohio
2020-11-12
Active, closed
Janssen Research & Development, LLC
Phase 1
144
Arizona, California, Florida, Illinois, Louisiana, Minnesota, Nebraska, New York
2020-11-12
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana, Massachusetts
2019-06-11
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Alabama, Arizona, California, Colorado, Connecticut, Florida, Idaho, Illinois
2015-11-19
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 1
57
California, Texas
2014-07-09
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Alabama, Alaska, Arizona, California, Colorado, District of Columbia, Florida, Idaho
2013-10-14
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-usa/condition/prostatic-neoplasms

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,164 studies in total at the last sync on 27 Oct 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies listing the condition Prostatic Neoplasms.

How many Prostatic Neoplasms trials are recruiting in the US?

11 of the 24 studies on this page are recruiting new participants as of the 27 Oct 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Prostatic Neoplasms), 24 studies
PhaseStudiesRecruitingShare
Phase 312350%
Phase 19537.5%
Observational114.2%
Phase 1/2114.2%
Phase 2114.2%

Most active sponsors

Lead sponsors with the most studies (Prostatic Neoplasms)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC105
Aragon Pharmaceuticals, Inc.40
Merck Sharp & Dohme LLC22
Novartis Pharmaceuticals20
Bayer11
Clarity Pharmaceuticals Ltd11
Eli Lilly and Company10
Flare Therapeutics Inc.11
Janssen Pharmaceutica N.V., Belgium10
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.11

Top states

Top states (Prostatic Neoplasms), by number of studies with a site there
StateStudies
Florida16
California14
Colorado12
Arizona11
New York8
Georgia7
Illinois7
Connecticut6
Louisiana6
Alabama4
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.